James C. Foster - Aug 1, 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Signature
/s/ James C. Foster
Stock symbol
CRL
Transactions as of
Aug 1, 2024
Transactions value $
-$6,250,000
Form type
4
Date filed
8/5/2024, 04:04 PM
Previous filing
Jun 4, 2024
Next filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Sale -$6.25M -25K -11.72% $250.00* 188K Aug 1, 2024 Direct F1
holding CRL Common Stock 7.58K Aug 1, 2024 2022 GRAT
holding CRL Common Stock 9.79K Aug 1, 2024 2023 GRAT F2
holding CRL Common Stock 20K Aug 1, 2024 2024 GRAT F3
holding CRL Common Stock 230 Aug 1, 2024 by Trust F4
holding CRL Common Stock 750 Aug 1, 2024 By Trust
holding CRL Common Stock 2.25K Aug 1, 2024 By Trust
holding CRL Common Stock 10K Aug 1, 2024 Held By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 26, 2024.
F2 On 6/5/2024, 10,207 shares were transferred from the 2023 GRAT account to Direct holdings.
F3 On 6/6/2024, 20,000 shares were transferred from Direct holdings to 2024 GRAT account.
F4 Reflects a reduction by 110 shares that were inadvertently reported as being held by the Reporting Person.